ADVENZYMES
1 call
Concalls & earnings callsAdvanced Enzyme Technologies Limited
Every summarised call, newest first. Latest is Q1 FY27, held 18 Aug 2026.
Latest quarter
Q1 FY27 snapshot
Open full brief →Advanced Enzyme Technologies reported a muted quarter impacted by sales reversals and global disruptions, but management maintains confidence in achieving double-digit annual growth.
| Metric | This quarter | Change | Five-quarter trend |
|---|---|---|---|
| Revenue | ₹189.8 Cr | 2% YoY | |
| EBITDA | ₹51 Cr | -10% YoY | |
| EBITDA Margin | 27% | — | |
| PAT | ₹38.6 Cr | -5% YoY |
Latest guidance
- Management is confident in delivering sustainable revenue growth consistent with annual guidance.
- Expects double-digit growth for the year.
- Anticipates EBITDA margins to recover to the normal level of about 30%.
- Expects progressive momentum as the year advances.
Said on the Q1 FY27 call.
Filed results
Reported quarterly history
From filed quarterly results. YoY and QoQ compare each metric on the same accounting basis.
| Quarter | Revenue | Net profit (PAT) | Basic EPS |
|---|---|---|---|
| Q3 FY25 | ₹169.11 Cr+5.1% YoY+15.8% QoQ | ₹38.88 Cr-8.5% YoY+16.4% QoQ | ₹3.36-10.2% YoY+14.3% QoQ |
| Q2 FY25 | ₹146.09 Cr-7.4% YoY-5.5% QoQ | ₹33.39 Cr-5.1% YoY-4.5% QoQ | ₹2.94-4.5% YoY-3.6% QoQ |
| Q1 FY25 | ₹154.52 Cr+4.9% YoY-2.1% QoQ | ₹34.98 Cr+19.1% YoY+17.1% QoQ | ₹3.05+18.2% YoY+20.6% QoQ |
| Q4 FY24 | ₹157.81 Cr+13.8% YoY-1.9% QoQ | ₹29.87 Cr-7% YoY-29.7% QoQ | ₹2.53-11.8% YoY-32.4% QoQ |
| Q3 FY24 | ₹160.94 Cr+13.3% YoY+2% QoQ | ₹42.50 Cr+52.3% YoY+20.7% QoQ | ₹3.74+42.2% YoY+21.4% QoQ |
Call history
- Q1 FY27Cautious tone
Advanced Enzyme Technologies reported a muted quarter impacted by sales reversals and global disruptions, but management maintains confidence in achieving double-digit annual growth.
- Revenue
- ₹189.8 Cr2% YoY
- EBITDA
- ₹51 Cr-10% YoY